Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
06:00pm, Wednesday, 03'rd Jun 2026
Reinforces Seer's Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity Illustrates Why Radoff and Torok's Short-Term Campaign Risks Disrupting Seer's Momentum and Und
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
09:00am, Saturday, 30'th May 2026
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in
Seer Files ITC Complaint Against Nanomics
07:00am, Friday, 29'th May 2026
Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group” or “we”), who collectively own approximately 7.8% of the outsta
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
04:05pm, Tuesday, 26'th May 2026
REDWOOD CITY, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the 2026 A
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
04:38pm, Thursday, 21'st May 2026
REDWOOD CITY, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (th
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.
08:00am, Thursday, 14'th May 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok, who collectively own approximately 7.8% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (the “Company”), today submitted the f
Seer Q1 Earnings Call Highlights
12:14am, Thursday, 14'th May 2026
Seer NASDAQ: SEER reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and exp
Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
07:00pm, Wednesday, 13'th May 2026
Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
04:05pm, Wednesday, 13'th May 2026
REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announc
Seer Files Patent Infringement Lawsuit Against Nanomics
07:00am, Wednesday, 13'th May 2026
Seer defends its pioneering Proteograph® Product Suite intellectual property (IP) REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for d
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
07:00am, Monday, 04'th May 2026
Seasoned life sciences executive brings extensive global commercial leadership to accelerate growth and expand adoption of Seer's Proteograph® Product Suite REDWOOD CITY, Calif., May 04, 2026 (GLOBE
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
04:05pm, Wednesday, 29'th Apr 2026
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial
The Radoff-JEC Group Responds to Seer, Inc.'s Rejection of April 24th Acquisition Proposal
08:00am, Wednesday, 29'th Apr 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group” or “we”), who collectively own approximately 7.6% of the outsta
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
07:00am, Monday, 27'th Apr 2026
REDWOOD CITY, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today annou
